Skip to main content
Log in

Investigation of c-myc and p53 Gene Alterations in the Tumor and Surgical Borderline Tissues of NSCLC and Effects on Clinicopathologic Behavior: By the FISH Technique

  • Published:
Lung Aims and scope Submit manuscript

Abstract

Genetic alterations on the primary tumoral tissues and surgical borderline tissues of 51 patients with NSCLC on which radiotherapy and chemotherapy had not been performed were analyzed by using the FISH method with locus-specific probes for p53 tumor suppressor gene and c-myc oncogene and centromere-specific probes for chromosome 17 and chromosome 8 on which these genes are located. P53 deletions were detected in 7 patients (13.7%), c-myc amplification in 4 patients (7.8%), monosomy 17 in 2 patients (3.9%) and trisomy 8 in 3 patients (5.8%), and a high level of polyploidy in tumoral tissues of 6 patients (11.7%). P53 deletion and c-myc amplification were found at surgical borderlines of 2 patients and 1 patient, respectively. Although both p53 deletion and c-myc amplification have low frequency at surgical border tissues, not only their detection is important for the follow-up of recurrency and metastasis, but it is also important for genetical and pathological staging. The results of this study show that c-myc amplification in NSCLC is related to the shortening of survival (p < 0.01). C-myc amplification and p53 deletion are also effective for the occurrence of metastasis (p < 0.05) and the effect of c-myc amplification in this matter is much higher than p53 deletion. The gain or loss of copy number of chromosome 8 and monosomy 17 show parallel effects with c-myc amplification and p53 deletion, respectively, on the clinicopathological behavior of tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. JM Anta De E Jassem R Rosell MM Roca J Jassem EM Lopez M Monzo JJS Hernandez I Moreno MS Cespedes (1997) ArticleTitleTP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis. Oncogene 15 2951–2958 Occurrence Handle10.1038/sj.onc.1201475 Occurrence Handle9416838

    Article  PubMed  Google Scholar 

  2. JA Brennan L Mao RH Hruban JO Boyle YJ Eby WM Koch Sn Goodman D Sidransky (1995) ArticleTitleMolecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 332 429–435 Occurrence Handle1:STN:280:ByqC38vktlY%3D Occurrence Handle7619114

    CAS  PubMed  Google Scholar 

  3. S Chen Y Gao X Dong Y Lu Q An T Tong Y Wang (2001) ArticleTitleMolecular and cytogenetic alterations in the early stage of carcinogenesis of human lung. Cancer Lett 162 5–10 Occurrence Handle10.1016/S0304-3835(00)00641-8

    Article  Google Scholar 

  4. TA D’amico TA Aloia MBH Moore JE Herndon KR Brooks CL Lau DH Harpole (2000) ArticleTitleMolecular biologic substaging of stage I lung cancer according to gender and histology. Ann Thorac Surg 69 882–886 Occurrence Handle10.1016/S0003-4975(99)01522-2 Occurrence Handle1:STN:280:DC%2BD3c3ht1yitw%3D%3D Occurrence Handle10750777

    Article  CAS  PubMed  Google Scholar 

  5. H Dosaka-Akita Sx Hu M Fujina M Harada I Kinoshita Hj Xu N Kuzumaki Y Kawakami WF Benedict (1997) ArticleTitleAltered retinoblastoma protein expression in non-small cell lung cancer. Cancer 79 1329–1337 Occurrence Handle10.1002/(SICI)1097-0142(19970401)79:7<1329::AID-CNCR9>3.3.CO;2-B Occurrence Handle1:STN:280:ByiB3snksFw%3D Occurrence Handle9083154

    Article  CAS  PubMed  Google Scholar 

  6. Ekmekçi A, Erbaş D (1991) Kanserin moleküler mekanizması. 72 TDFO tesisleri, Ankara, pp 57–143

  7. G Fontanini S Vignati D Bigini A Mussi M Lucchi S Chine Ca Angeletti G Bevilacqua (1996) ArticleTitleRecurrence and death in non-small cell lung carcinomas: a prognostic model using pathological parameters, microvessel count, and gene protein products. Clin Cancer Res 2 1067–1075 Occurrence Handle1:STN:280:DyaK1M%2FjsFWitQ%3D%3D Occurrence Handle9816269

    CAS  PubMed  Google Scholar 

  8. AF Gazdar DN Carney H Oie E Russell MM Nau JD Minna (1987) ArticleTitleMyc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course. J Clin Invest 79 1629–1634 Occurrence Handle3034978

    PubMed  Google Scholar 

  9. S Gazzeri E Brambilla CC Fromentel V Gouyer D Moro P Perron F Berger C Brambılla (1994) ArticleTitleP53 genetic abnormalities and myc activation in human lung carcinoma. Int J Cancer 58 24–32 Occurrence Handle1:CAS:528:DyaK2cXlsFCnsb8%3D Occurrence Handle8014012

    CAS  PubMed  Google Scholar 

  10. M Huncharek B Kupelnick JF Geschwind JF Caubet (2000) ArticleTitlePrognostic significance of p53 mutations in non-small cell lung cancer: a meta-analysis of 829 cases from eight published studies. Cancer Lett 153 219–226 Occurrence Handle10.1016/S0304-3835(00)00381-5 Occurrence Handle1:CAS:528:DC%2BD3cXisFGlsr4%3D Occurrence Handle10779652

    Article  CAS  PubMed  Google Scholar 

  11. BE Johnson RW Makuch AD Simmons AF Gazdar D Bruch AW Cashell (1988) ArticleTitleMyc family DNA amplification in small cell lung cancer patients tumors and corresponding cell lines. Cancer Res 48 5163–5166 Occurrence Handle1:CAS:528:DyaL1cXls1yiu7k%3D Occurrence Handle2842046

    CAS  PubMed  Google Scholar 

  12. E Kettunen WE Rıfai AM Bjorkqvıst H Wolff A Karjalainen S Anttılla K Mattson KH Pusiainen S Knuutila (2000) ArticleTitleA broad amplification pattern at 3q in squamous cell lung cancer a fluorescence in situ hybridization study. Cancer Genet Cytogen 117 66–70 Occurrence Handle10.1016/S0165-4608(99)00146-6 Occurrence Handle1:CAS:528:DC%2BD3cXhtFagtrs%3D

    Article  CAS  Google Scholar 

  13. TC King V Akerley AC Fan T Moore S Mangray MH Chen H Safran (2000) ArticleTitleP53 mutations do not predict response to paclitaxel in metastatic non-small cell lung carcinoma. Cancer 89 769–773 Occurrence Handle10.1002/1097-0142(20000815)89:4<769::AID-CNCR8>3.0.CO;2-6 Occurrence Handle1:CAS:528:DC%2BD3cXmtFOnu7w%3D Occurrence Handle10951339

    Article  CAS  PubMed  Google Scholar 

  14. JP Lavieille E Brambilla C Riva-Lavieille E Reyt R Charachon C Brambilla (1995) ArticleTitleImmunohistochemical detection of p53 protein in preneoplastic lesions and squamous cell carcinoma of the head and neck. Acta Otolaryngol 115 334–339 Occurrence Handle1:STN:280:ByqA3sritFY%3D Occurrence Handle7610836

    CAS  PubMed  Google Scholar 

  15. A Marchetti F Buttitta G Merlo F Diella S Pellegrini S Pepe P Macchiarini A Chella CA Angelett R Callahan M Bistocchi F Squartini (1993) ArticleTitleP53 alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes. Cancer Res 53 2846–2851

    Google Scholar 

  16. T Mitsudomi SM Steinberg MM Nau D Carbone D D’amico S Bodner HK Oie RI Linnoila JL Mulshine JD Minna AF Gazdar (1992) ArticleTitleP53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7 171–180 Occurrence Handle1:CAS:528:DyaK38XhslWhtb0%3D Occurrence Handle1311061

    CAS  PubMed  Google Scholar 

  17. MM Nau DN Carney J Battey B Johnson C Little A Gazdar JD Minna (1984) ArticleTitleAmplification, expression and rearrangement of c-myc and n-myc oncogenes in human lung cancer. Curr Topics Microbiol Immunol 113 172–177 Occurrence Handle1:CAS:528:DyaL2MXhtFKi

    CAS  Google Scholar 

  18. M Noguchi S Hirohashi F Hara A Kojima Y Shimosato T Shinkai R Tsuchiya (1990) ArticleTitleHeterogenous amplification of myc family oncogenes in small cell lung carcinoma. Cancer 66 2053–2058 Occurrence Handle1:STN:280:By6D38bgsFA%3D Occurrence Handle2171744

    CAS  PubMed  Google Scholar 

  19. HA Ozkara S Ozkara S Topçu WE Criss (1999) ArticleTitleAmplification of the c-myc oncogene in non-small-cell lung cancer. Tumor 85 508–511 Occurrence Handle1:CAS:528:DC%2BD3cXitVCnurs%3D

    CAS  Google Scholar 

  20. A Pifarre R Roselli M Monzo Jmd Anta I Moreno JJ Sanchez A Ariza JL Mate E Martınez (1997) ArticleTitlePrognostic value of replication errors on chromosome 2p and 3p in non-small cell lung cancer. Br J Cancer 75 184–189 Occurrence Handle1:CAS:528:DyaK2sXhtFGks78%3D Occurrence Handle9010024

    CAS  PubMed  Google Scholar 

  21. CM Riva (2000) ArticleTitleRetoration of wild-type p53 activity enhances the sensitivity of pleural metastasis to cisplatin through an apoptotic mechanism. Anticancer Res 20 4463–4472 Occurrence Handle1:CAS:528:DC%2BD3MXhtVejsLk%3D Occurrence Handle11205289

    CAS  PubMed  Google Scholar 

  22. WN Rom JG Hay TC Lee Y Jiang KM Tchou-Wong (2000) ArticleTitleMolecular and genetic aspects of lung cancer. Am J Resp Crit Care 161 1355–1367 Occurrence Handle1:STN:280:DC%2BD3c3isl2ntA%3D%3D

    CAS  Google Scholar 

  23. N Sawabata T Mori K Luchi H Maeda M Ohta O Kuwahara (1999) ArticleTitleCytologic examination of surgical margin of excised malignant pulmonary tumor: methods and early results. J Thorac Cardiov Surg 117 618–619 Occurrence Handle1:STN:280:DyaK1M7lvV2jtQ%3D%3D Occurrence Handle10047671

    CAS  PubMed  Google Scholar 

  24. T Schenk J Ackermann C Brunner P Schenk N Zojer S Roka J Drach (1997) ArticleTitleDetection of chromosomal aneuploidy by interphase in situ hybridization in bronchoscopically gained cells from lung cancer patients. Chest 111 1691–1696 Occurrence Handle1:STN:280:ByiA3s%2FntlI%3D Occurrence Handle9187195

    CAS  PubMed  Google Scholar 

  25. R Shipman P Schraml M Colombi G Raefle P Dalquen C Ludwing (1996) ArticleTitleFrequent p53 gene alterations (mutation, allelic loss, nuclear accumulation) in primary non-small-cell lung cancer. Eur J Cancer 32A 335–341 Occurrence Handle10.1016/0959-8049(95)00535-8 Occurrence Handle1:CAS:528:DyaK28Xitl2hsbc%3D Occurrence Handle8664051

    Article  CAS  PubMed  Google Scholar 

  26. M Shiraishi M Noguchi Y Shimosato T Sekiya (1989) ArticleTitleAmplification of protooncogenes in surgical specimens of human lung carcinomas. Cancer Res 49 6474–6479 Occurrence Handle1:CAS:528:DyaK3cXjtFGgug%3D%3D Occurrence Handle2573414

    CAS  PubMed  Google Scholar 

  27. V Skaug D Ryberg EH Arabkmo L Stangeland AO Myking A Haugen (2000) ArticleTitleP53 mutations in defined structural and functional domains are related to poor clinical outcome in non-small cell lung cancer patients. Clin Cancer Res 6 1031–1037 Occurrence Handle1:CAS:528:DC%2BD3cXisVaqu7w%3D Occurrence Handle10741731

    CAS  PubMed  Google Scholar 

  28. MR Speicher S Petersen S Uhrig I Jentsch C Fauth R Eils I Petersen (2000) ArticleTitleAnalysis of chromosomal alterations in non-small-cell lung cancer by multiplex-fish, comparative genomic hybridization, and multicolor bar coding. Lab Invest 80 1031–1041 Occurrence Handle1:CAS:528:DC%2BD3cXlsF2iur4%3D Occurrence Handle10908148

    CAS  PubMed  Google Scholar 

  29. T Takahashi Y Obata Y Sekido T Hida R Ueda H Watanabe Y Ariyoshi T Sugiura T Takahashi (1989) ArticleTitleExpression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics. Cancer Res 49 2683–2688 Occurrence Handle1:CAS:528:DyaL1MXktVGisLs%3D Occurrence Handle2540905

    CAS  PubMed  Google Scholar 

  30. Y Taya K Hosogai S Hirohashi Y Shimosato R Tsuchiya N Tsuchida M Fushimi T Sekiya S Nishimura (1984) ArticleTitleA novel combination of K-ras and myc amplification accompanied by point mutational activation of K-ras in a human lung cancer. EMBO J 3 2943–2946 Occurrence Handle1:CAS:528:DyaL2MXktVyquw%3D%3D Occurrence Handle6098458

    CAS  PubMed  Google Scholar 

  31. Jr Testa SL Graziano (1993) ArticleTitleMolecular implications of recurrent cytogenetic alterations in human small cell lung cancer. Cancer Detect Prev 17 267–277 Occurrence Handle1:CAS:528:DyaK3sXmt1art74%3D Occurrence Handle8402711

    CAS  PubMed  Google Scholar 

  32. JA Williams ZR Wang RS Parrish LJ Hazlett ST Smith SR Young (1999) ArticleTitleFluorescence in situ hybridization analysis of HER-2/neu, c-myc, and p53 in endometrial cancer. Exp Mol Pathol 67 135–143 Occurrence Handle10.1006/exmp.1999.2289 Occurrence Handle1:CAS:528:DyaK1MXnvFaqsbw%3D Occurrence Handle10600396

    Article  CAS  PubMed  Google Scholar 

  33. T Yamada T Kohno JM Navarro S Ohwada M Perucho J Yokota (2000) ArticleTitleFrequent chromosome 8q gains in human small cell lung carcinoma detected by arbitrarily primed-pcr genomic fingerprinting. Cancer Genet Cytogen 120 11–17 Occurrence Handle10.1016/S0165-4608(99)00240-X Occurrence Handle1:CAS:528:DC%2BD3cXksFGjtrw%3D

    Article  CAS  Google Scholar 

  34. S Zienolddiny D Ryberg Mo Arab V Skaug A Haugen (2001) ArticleTitleLoss of heterozygosity is related to p53 mutations and smoking in lung cancer. Br J Cancer 84 226–231 Occurrence Handle10.1054/bjoc.2000.1528 Occurrence Handle1:CAS:528:DC%2BD3MXht1Wgsr4%3D Occurrence Handle11161381

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Drs. Bulent Ediz and Ilker Ercan for helping with statistical analysis, Dr. Nur Urer for pathological support, and Medical Biolog Barboros Yigit for his technical assistance. This study was supported by Research Foundation of Uludag University (Project number: 2001/39).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. Yakut.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yakut, T., Egeli, U. & Gebitekin, C. Investigation of c-myc and p53 Gene Alterations in the Tumor and Surgical Borderline Tissues of NSCLC and Effects on Clinicopathologic Behavior: By the FISH Technique . Lung 181, 245–258 (2003). https://doi.org/10.1007/s00408-003-1026-x

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-003-1026-x

Keywords

Navigation